10 Takeover Targets to Watch This Fall
Pace of Biopharma M&A Slows from First Half Stampede of Deals
In the mAb Race, Don’t Stumble at Characterization
Researchers Adapt Existing Techniques to Deal with Challenging New Monoclonal Antibodies
Bioprocessing Companies Push Limits of Upstream Technologies
Goal Is to Maximize Efficiency in Bioprocess Operations
Marijuana Use in Adults Living with Sickle Cell Disease
Most States Do Not Specify Sickle Cell Disease as a Qualifying Condition for Legal Access to Marijuana
For full access to this article login to GEN Select now.
Supplement: HSP90 Inhibition Turns Up the Heat on Tumors
If “Cold” Tumors Become “Hot,” They Respond Better to Checkpoint Blockade Immunotherapy
- The emergence and stunning early success of checkpoint blockade, a therapy that helps the immune system recognize and attack cancer cells, has garnered well-deserved headlines. Checkpoint blockade, however, benefits only a minority of cancer patients. While these patients harbor tumors that are responsive to checkpoint drugs such as anti-PD-1 ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.